Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Patent
1999-03-29
1999-11-16
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
514497, 514183, 514634, A61K 3128, A61K 3131, A61K 31155, A61K 3133
Patent
active
059859172
ABSTRACT:
This invention is directed to a pharmacologically acceptable composition for inhibiting nitric oxide synthase in a mammal, which includes a mercapto or seleno derivative and a pharmaceutically acceptable carrier. The invention also concerns a method of inhibiting nitric oxide synthase, selectively inhibiting the inducible isoform of nitric oxide synthase, and treating various conditions where there is an advantage in inhibiting nitric oxide biosynthesis. The method includes the step of administering to a mammal a mercapto or seleno derivative in pure form or in a pharmaceutically acceptable carrier.
REFERENCES:
patent: 5298506 (1994-03-01), Stamler et al.
Khym et al., "Ion Exchange Studies of Transguanylation Reactions. II. . . . and 2-Aminothiazolines or Penthiazolines", Journal of the American Chemical Society, vol. 80, pp. 3342-3349, Jul. 5, 1958.
Doherty et al., "Synthesis of D- and L-2-Aminobutylisothiourea Dihydrobromide Isomers and their Conversion to Guanidothiols, Disulphides, and Thiazolines", Journal of Organic Chemistry, vol. 28, pp. 1339-1342, 1963.
Chemical Abstracts, vol. 82, 1975, p. 12, #164694y, Tumor rejection in experimental animals treated with radioprotective thiols.
Cancer Research, 35. 429-437., Feb. 1975, Tumor Rejection in Experimental Animals Treated with Radioprotective Thiols.
Szabo et al., "Beneficial effects and improved survival in rodent models . . . nitric oxide synthase", Pharmacology, vol. 91, pp. 12472-12476. Dec. 1994.
Southan et al., "Isothioureas: potent inhibitors of nitric oxide synthases . . . selectivity", British Journal of Pharmacology, vol. 114, pp. 510-516, 1995.
Wu et al., "Aminoguanidine attenuates the delayed circulatory failure and . . . shock" British Journal of Pharmacology, vol. 113, pp. 001-007, Paper No. 78594, 1994.
Khym et al., "Ion Exchange Studies of Transguanylation Reactions. I. Rearrangement of S,2-Aminoethylisothiourea . . . Aminothiazoline", Journal of the American Chemical Society, vol. 79, pp. 5663-5666, Nov. 5, 1957.
Doherty et al., "Synthesis of Aminoalkylisothiuronium Salts and their Conversion to Mercaptoalkylguanidines and Thiazolines", Journal of the American Chemical Society, vol. 79, pp. 5667-5671, Nov. 5, 1957.
Chu, S., et al., "Potential Antiradiation Agents. II. Selenium Analogs of 2-Aminoethylisothiouronium Hydrobromide and Related Compounds," Journal of the American Chemical Society, vol. 27, pp. 2899-2901, Aug. 1962.
Hino, T., et al., "Radiation-protective Agents. I. Sutdies on N-Alkylated-2-(2-aminoethyl)thiopseudoureas and 1,1-(Dithioethylene)diguanidines", Chemical & Pharmaceutical Bulletin, vol. 14, No. 11, pp. 1193-1201, Nov. 1966.
Salzman Andrew L.
Southan Garry J.
Szabo Csaba
Children's Hospital Medical Center
Criares Theodore J.
LandOfFree
Mercapto and seleno derivatives as inhibitors of nitric oxide sy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mercapto and seleno derivatives as inhibitors of nitric oxide sy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mercapto and seleno derivatives as inhibitors of nitric oxide sy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1325310